{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:03:08Z","timestamp":1786989788753,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.gcb.2010.09.008","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T04:12:52Z","timestamp":1288757572000},"page":"590-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Enteropathy-associated T-cell lymphoma: A review on clinical presentation, diagnosis, therapeutic strategies and perspectives"],"prefix":"10.1016","volume":"34","author":[{"given":"M.-O.","family":"Chandesris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Malamut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Verkarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Meresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-T.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Deau-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cerf-Bensussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2010.09.008_bib0005","series-title":"World Health Organisation classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues","first-page":"208","article-title":"Enteropathy-type T-cell lymphoma","author":"Isaacson","year":"2001"},{"key":"10.1016\/j.gcb.2010.09.008_bib0010","series-title":"World Health Organisation classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues","first-page":"289","article-title":"Enteropathy-associated T-cell lymphoma","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.gcb.2010.09.008_bib0015","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. The non-Hodgkin's lymphoma classification project. Blood 1997; 89:3909\u201318.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"10.1016\/j.gcb.2010.09.008_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0025","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM199611213352117","article-title":"Celiac disease and T-cell lymphoma","volume":"335","author":"Egan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2010.09.008_bib0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJM198009043031014","article-title":"Case 15-1980: celiac disease and intestinal lymphoma","volume":"303","author":"Isaacson","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2010.09.008_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.2003.032094","article-title":"Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T\u00a0cell lymphoma","volume":"54","author":"Medby","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0040","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(83)91371-5","article-title":"Coeliac disease and malignancy","volume":"1","author":"Isaacson","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0045","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0050","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0060","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2003.06.026","article-title":"Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German study group on intestinal non-Hodgkin's lymphoma","volume":"21","author":"Daum","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0065","first-page":"191","article-title":"A single-center report on clinical features and treatment response in patients with intestinal T\u00a0cell non-Hodgkin's lymphomas","volume":"16","author":"Novakovic","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.gcb.2010.09.008_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199509000-00012","article-title":"Celiac-associated lymphoma. A single institution experience of 30\u00a0cases in the combination chemotherapy era","volume":"21","author":"Egan","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MEG.0b013e328307c20c","article-title":"High rates of complications and substantial mortality in both types of refractory sprue","volume":"21","author":"Daum","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type\u00a0I with type\u00a0II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0085","first-page":"369","article-title":"Fatty stools from disease of the mesenteric glands","volume":"1","author":"Gull","year":"1855","journal-title":"Guys Hosp Rep"},{"key":"10.1016\/j.gcb.2010.09.008_bib0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.3.3.232","article-title":"Intestinal reticulosis as a complication of idiopathic steatorrhoea","volume":"3","author":"Gough","year":"1962","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0046-8177(78)80049-5","article-title":"Malignant histiocytosis of the intestine. Its relationship to malabsorption and ulcerative jejunitis","volume":"9","author":"Isaacson","year":"1978","journal-title":"Hum Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(78)90004-1","article-title":"Intestinal lymphoma associated with malabsorption","volume":"1","author":"Isaacson","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01333708","article-title":"Malignant histiocytosis of the intestine","volume":"24","author":"Hodges","year":"1979","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gcb.2010.09.008_bib0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(85)92930-7","article-title":"Malignant histiocytosis of the intestine: a T-cell lymphoma","volume":"2","author":"Isaacson","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1008278706002","article-title":"From the R.E.A.L. classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities?","volume":"9","author":"Pileri","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174\u00a0patients diagnosed according to the R.E.A.L. classification","volume":"9","author":"L\u00f3pez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0125","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gcb.2010.09.008_bib0130","first-page":"1","article-title":"T\u00a0cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes","volume":"132","author":"Spencer","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1023\/A:1008439620513","article-title":"Report of the European task force on lymphomas: workshop on peripheral T-cell lymphomas","volume":"9","author":"Campo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0140","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mi.2008.75","article-title":"Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis","volume":"2","author":"Meresse","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0150","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(84)90822-5","article-title":"Suppressor-cell activity in coeliac disease induced by alpha-gliadin, a dietary antigen","volume":"2","author":"O\u2019Farrelly","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/00365528309181645","article-title":"The specificity of wheat protein reactivity in coeliac disease","volume":"18","author":"O\u2019Farrelly","year":"1983","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gcb.2010.09.008_bib0160","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1172\/JCI27620","article-title":"HLA-DQ2 and -DQ8 signatures of gluten T\u00a0cell epitopes in celiac disease","volume":"116","author":"Tollefsen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gcb.2010.09.008_bib0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2009.03.004","article-title":"Antigen presentation in celiac disease","volume":"21","author":"Qiao","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"21","key":"10.1016\/j.gcb.2010.09.008_bib0170","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","article-title":"The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T\u00a0cell responses","volume":"100","author":"Vader","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gcb.2010.09.008_bib0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJMra010852","article-title":"Celiac sprue","volume":"346","author":"Farrell","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2010.09.008_bib0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin\u00a015 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V94.1.260.413k40_260_264","article-title":"Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population","volume":"94","author":"Bagdi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.gcb.2010.09.008_bib0200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/gut.2005.079335","article-title":"Interleukin\u00a015: its role in intestinal inflammation","volume":"55","author":"van Heel","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0210","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/j.gastro.2006.12.025","article-title":"Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease","volume":"132","author":"Benahmed","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0215","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1053\/j.gastro.2007.01.062","article-title":"Mucosal inflammation in celiac disease: interleukin-15 meets transforming growth factor beta-1","volume":"132","author":"Kagnoff","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0220","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin\u00a015: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0225","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","article-title":"Are complicated forms of celiac disease cryptic T-cell lymphomas?","volume":"92","author":"Carbonnel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.gcb.2010.09.008_bib0230","first-page":"32","article-title":"Refractory coeliac disease: a window between coeliac disease and enteropathy associated T\u00a0cell lymphoma","volume":"232","author":"Mulder","year":"2000","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.gcb.2010.09.008_bib0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000007779","article-title":"Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma","volume":"62","author":"Daum","year":"2000","journal-title":"Digestion"},{"key":"10.1016\/j.gcb.2010.09.008_bib0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(03)00692-9","article-title":"Recurrent partial trisomy\u00a01q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue","volume":"125","author":"Verkarre","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0245","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/path.1506","article-title":"Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma","volume":"202","author":"Obermann","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1309\/NW2BK1DXB0EQG55H","article-title":"Enteropathy-type T-cell lymphoma","volume":"127","author":"Zettl","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0255","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"16","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.11.026","article-title":"Celiac disease and its complications: a time traveller's perspective","volume":"136","author":"West","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0270","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(01)05554-4","article-title":"Mortality in patients with coeliac disease and their relatives: a cohort study","volume":"358","author":"Corrao","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0275","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1023\/A:1026655609906","article-title":"Mortality and causes of death in celiac disease in a Mediterranean area","volume":"44","author":"Cottone","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gcb.2010.09.008_bib0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.gastro.2008.09.031","article-title":"Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association","volume":"136","author":"Gao","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0285","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gut.30.3.333","article-title":"Malignancy in coeliac disease\u00a0\u2013\u00a0effect of a gluten free diet","volume":"30","author":"Holmes","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/path.1711770203","article-title":"Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13\u00a0cases of enteropathy-associated T- and B-cell lymphoma","volume":"177","author":"Ilyas","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0295","first-page":"1361","article-title":"Peripheral T-cell lymphomas of the intestine","volume":"141","author":"Chott","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0300","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/147323000703500316","article-title":"Primary small-bowel non-Hodgkin's lymphoma: a study of clinical features, pathology, management and prognosis","volume":"35","author":"Yin","year":"2007","journal-title":"J Int Med Res"},{"key":"10.1016\/j.gcb.2010.09.008_bib0305","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3748\/wjg.v13.i11.1696","article-title":"Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma","volume":"13","author":"Mallant","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0310","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/00365520600727792","article-title":"Milestone in gastrointestinal endoscopy: double-balloon enteroscopy of the small bowel","volume":"243","author":"Heine","year":"2006","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.gcb.2010.09.008_bib0315","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1572-0241.2007.01122.x","article-title":"The value of double-balloon enteroscopy in patients with refractory celiac disease","volume":"102","author":"Hadithi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.52.3.347","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T\u00a0cell lymphoma","volume":"52","author":"Hoffmann","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2010.09.008_bib0325","first-page":"1622","article-title":"18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease","volume":"47","author":"Hadithi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.gcb.2010.09.008_bib0330","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-2005-861322","article-title":"Capsule endoscopy findings in celiac disease associated enteropathy-type intestinal T-cell lymphoma","volume":"37","author":"Joyce","year":"2005","journal-title":"Endoscopy"},{"key":"10.1016\/j.gcb.2010.09.008_bib0335","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2007-966239","article-title":"Capsule endoscopy in refractory celiac disease","volume":"39","author":"Daum","year":"2007","journal-title":"Endoscopy"},{"key":"10.1016\/j.gcb.2010.09.008_bib0340","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T\u00a0cells","volume":"109","author":"Al-Toma","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.gcb.2010.09.008_bib0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0350","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-199305000-00001","article-title":"Primary lymphoma of the small intestine. A clinicopathological study of 119\u00a0cases","volume":"17","author":"Domizio","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0355","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.1997.2660862.x","article-title":"Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype","volume":"31","author":"de Bruin","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0360","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2169\/internalmedicine.41.734","article-title":"CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"41","author":"Okuda","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.gcb.2010.09.008_bib0365","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+ CD5\u2212 T-cell lymphomas of monomorphic small to medium size histology","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0370","series-title":"Evidence-based medicine: how to practice and teach EBM","author":"Sackett","year":"2000"},{"key":"10.1016\/j.gcb.2010.09.008_bib0375","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.dld.2007.04.009","article-title":"A matter of early diagnosis and chemotherapy strategies","volume":"39","author":"Ciccocioppo","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gcb.2010.09.008_bib0380","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood.V112.11.578.578","volume":"112","author":"Sieniawski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.gcb.2010.09.008_bib0385","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.dld.2007.03.009","article-title":"Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma","volume":"39","author":"Al-Toma","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gcb.2010.09.008_bib0390","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/0016-5085(93)91061-L","article-title":"Primary digestive tract lymphoma: a prospective multicentric study of 91\u00a0patients","volume":"105","author":"Ruskon\u00e9-Fourmestraux","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.09.008_bib0395","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/annonc\/mdh427","article-title":"Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma","volume":"15","author":"W\u00f6hrer","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0400","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00277-004-0953-9","article-title":"Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options","volume":"84","author":"H\u00f6nemann","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0405","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2141.2007.06532.x","article-title":"Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma","volume":"137","author":"Lennard","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0410","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2006.06371.x","article-title":"Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T\u00a0cell lymphoma","volume":"136","author":"Bishton","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0415","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10620-006-8013-z","article-title":"Successful treatment of enteropathy-associated T\u00a0cell lymphoma with autologous stem cell transplant","volume":"51","author":"Rongey","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gcb.2010.09.008_bib0420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":"Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study","volume":"27","author":"Reimer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0425","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/1042819031000123456","article-title":"High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma","volume":"44","author":"Jantunen","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.gcb.2010.09.008_bib0430","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High-dose therapy with autologous stem cell transplantation in patients with peripheral T\u00a0cell lymphomas","volume":"27","author":"Blystad","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.gcb.2010.09.008_bib0435","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1053\/j.seminoncol.2006.01.029","article-title":"The role of alemtuzumab in the management of T-cell malignancies","volume":"33","author":"Dearden","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0440","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2008.07202.x","article-title":"Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma","volume":"142","author":"Soldini","year":"2008","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.gcb.2010.09.008_bib0445","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00001622-200409000-00002","article-title":"Mycosis fungoides and the Sezary syndrome","volume":"16","author":"Foss","year":"2004","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"10.1016\/j.gcb.2010.09.008_bib0450","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ctrv.2006.08.006","article-title":"Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma","volume":"33","author":"Whittaker","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.gcb.2010.09.008_bib0455","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMc061784","article-title":"Alemtuzumab for refractory celiac disease","volume":"355","author":"Verbeek","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2010.09.008_bib0460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/annonc\/mdn198","article-title":"New targets for lymphoma treatment","volume":"19","author":"Johnson","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0465","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1200\/JCO.2007.15.3429","article-title":"Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma","volume":"26","author":"Wiernik","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0470","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOH.0b013e3282f3deaa","article-title":"Exploiting the mammalian target of rapamycin pathway in hematologic malignancies","volume":"15","author":"Altman","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0475","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3747\/co.v15i5.371","article-title":"Histone deacetylase inhibitors as novel anticancer therapeutics","volume":"15","author":"Walkinshaw","year":"2008","journal-title":"Curr Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0480","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PPO.0b013e31803c7359","article-title":"DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies","volume":"13","author":"Fandy","year":"2007","journal-title":"Cancer J"},{"key":"10.1016\/j.gcb.2010.09.008_bib0485","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1200\/JCO.2008.20.8470","article-title":"Phase\u00a0II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies","volume":"27","author":"O\u2019Connor","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0490","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","article-title":"Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 francaise de greffe de mo\u00eblle et de th\u00e9rapie cellulaire","volume":"26","author":"Le Gouill","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0495","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1309\/EVXT-851X-WHLC-RLX9","article-title":"Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery","volume":"118","author":"Wahab","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.gcb.2010.09.008_bib0500","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Di Sabatino","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2010.09.008_bib0505","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1572-0241.1998.00439.x","article-title":"Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease","volume":"93","author":"Cellier","year":"1998","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832010003490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832010003490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:52:42Z","timestamp":1759974762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832010003490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":101,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0399832010003490"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2010.09.008","relation":{},"ISSN":["0399-8320"],"issn-type":[{"value":"0399-8320","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteropathy-associated T-cell lymphoma: A review on clinical presentation, diagnosis, therapeutic strategies and perspectives","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2010.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2010.01.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}